| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophage Colony-Stimulating Factor | 12 | 2020 | 14 | 1.700 |
Why?
|
| Calcinosis | 7 | 2015 | 11 | 1.640 |
Why?
|
| Arteriosclerosis | 11 | 2004 | 18 | 1.630 |
Why?
|
| Lipoproteins, LDL | 10 | 2011 | 11 | 1.110 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2020 | 22 | 0.880 |
Why?
|
| Macrophages | 8 | 2020 | 22 | 0.860 |
Why?
|
| Osteoclasts | 2 | 2015 | 3 | 0.780 |
Why?
|
| Gene Expression Regulation | 9 | 2011 | 93 | 0.740 |
Why?
|
| Animals | 32 | 2020 | 1238 | 0.720 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2015 | 17 | 0.660 |
Why?
|
| Humans | 32 | 2020 | 2493 | 0.630 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 2 | 0.580 |
Why?
|
| Neointima | 1 | 2016 | 2 | 0.580 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 2 | 0.560 |
Why?
|
| Giant Cells | 1 | 2015 | 2 | 0.560 |
Why?
|
| Mice | 19 | 2016 | 508 | 0.520 |
Why?
|
| Male | 19 | 2020 | 1649 | 0.510 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2011 | 7 | 0.430 |
Why?
|
| Inflammation Mediators | 3 | 2020 | 17 | 0.430 |
Why?
|
| Estradiol | 1 | 2011 | 50 | 0.410 |
Why?
|
| Coronary Vessels | 5 | 2005 | 12 | 0.410 |
Why?
|
| Female | 10 | 2020 | 1733 | 0.380 |
Why?
|
| RNA, Messenger | 15 | 2002 | 167 | 0.380 |
Why?
|
| Endothelium, Vascular | 6 | 2004 | 21 | 0.380 |
Why?
|
| Osteopetrosis | 3 | 2002 | 3 | 0.380 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 17 | 0.380 |
Why?
|
| Arteries | 4 | 2004 | 13 | 0.370 |
Why?
|
| Albuminuria | 3 | 2020 | 20 | 0.360 |
Why?
|
| Metalloendopeptidases | 2 | 1999 | 4 | 0.360 |
Why?
|
| Cells, Cultured | 12 | 2011 | 164 | 0.340 |
Why?
|
| Lipoproteins | 2 | 2005 | 4 | 0.310 |
Why?
|
| Membrane Glycoproteins | 4 | 2015 | 62 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2002 | 26 | 0.290 |
Why?
|
| Brachytherapy | 2 | 2004 | 2 | 0.280 |
Why?
|
| Mice, Knockout | 6 | 2020 | 112 | 0.280 |
Why?
|
| Middle Aged | 5 | 2020 | 799 | 0.280 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 14 | 0.270 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 11 | 0.270 |
Why?
|
| Angioplasty, Balloon | 2 | 2002 | 2 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 185 | 0.270 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 143 | 0.260 |
Why?
|
| Endocrine System | 1 | 2004 | 4 | 0.260 |
Why?
|
| Monocytes | 6 | 2011 | 13 | 0.250 |
Why?
|
| Interleukin-1 | 3 | 1999 | 10 | 0.250 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2004 | 4 | 0.250 |
Why?
|
| Bone and Bones | 1 | 2003 | 5 | 0.240 |
Why?
|
| Inflammation | 2 | 2003 | 44 | 0.240 |
Why?
|
| Receptors, LDL | 3 | 2020 | 5 | 0.240 |
Why?
|
| Coronary Restenosis | 2 | 2004 | 2 | 0.240 |
Why?
|
| Apolipoproteins E | 6 | 2011 | 14 | 0.230 |
Why?
|
| Cell Membrane | 1 | 2002 | 31 | 0.230 |
Why?
|
| Base Sequence | 14 | 1999 | 65 | 0.230 |
Why?
|
| Aged | 4 | 2020 | 607 | 0.230 |
Why?
|
| NF-kappa B | 6 | 2000 | 26 | 0.220 |
Why?
|
| Models, Biological | 1 | 2002 | 43 | 0.220 |
Why?
|
| Endothelial Cells | 2 | 2020 | 7 | 0.210 |
Why?
|
| Colony-Stimulating Factors | 4 | 1990 | 4 | 0.210 |
Why?
|
| Rats | 8 | 2016 | 432 | 0.210 |
Why?
|
| Apoptosis | 2 | 2020 | 162 | 0.210 |
Why?
|
| DNA | 7 | 1998 | 19 | 0.210 |
Why?
|
| Immunoblotting | 2 | 2016 | 12 | 0.200 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2011 | 7 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2020 | 14 | 0.190 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 23 | 0.190 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 28 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 1998 | 25 | 0.180 |
Why?
|
| Cell Proliferation | 1 | 2020 | 110 | 0.180 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 10 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 13 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 28 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2016 | 179 | 0.170 |
Why?
|
| Transcription, Genetic | 4 | 1999 | 34 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 148 | 0.150 |
Why?
|
| Rabbits | 2 | 2016 | 25 | 0.150 |
Why?
|
| African Americans | 1 | 2019 | 272 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 29 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 4 | 1998 | 25 | 0.140 |
Why?
|
| RNA-Binding Proteins | 2 | 1998 | 12 | 0.130 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 246 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2014 | 24 | 0.120 |
Why?
|
| Nitric Oxide | 4 | 2000 | 54 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1992 | 7 | 0.120 |
Why?
|
| Tunica Intima | 3 | 2004 | 4 | 0.120 |
Why?
|
| Molecular Sequence Data | 9 | 1998 | 62 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2008 | 79 | 0.120 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 18 | 0.120 |
Why?
|
| Amino Acid Sequence | 9 | 1997 | 45 | 0.120 |
Why?
|
| Growth Substances | 2 | 1990 | 6 | 0.110 |
Why?
|
| Cloning, Molecular | 5 | 1997 | 16 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 3 | 1997 | 74 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 2 | 0.110 |
Why?
|
| Adult | 3 | 2020 | 807 | 0.100 |
Why?
|
| Muscle Development | 2 | 2008 | 22 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2011 | 102 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2004 | 7 | 0.100 |
Why?
|
| Biological Evolution | 3 | 1992 | 5 | 0.100 |
Why?
|
| Time Factors | 1 | 2011 | 120 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 4 | 0.100 |
Why?
|
| Blotting, Northern | 2 | 2002 | 28 | 0.100 |
Why?
|
| Penis | 3 | 1997 | 110 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2011 | 18 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2002 | 42 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2002 | 29 | 0.100 |
Why?
|
| Gene Expression | 2 | 1996 | 73 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2011 | 53 | 0.100 |
Why?
|
| Aorta | 4 | 2020 | 16 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 3 | 2008 | 81 | 0.100 |
Why?
|
| Obesity | 1 | 2011 | 102 | 0.090 |
Why?
|
| Sterols | 1 | 1989 | 1 | 0.090 |
Why?
|
| Metalloproteins | 1 | 1989 | 2 | 0.090 |
Why?
|
| Gelatinases | 2 | 1999 | 2 | 0.090 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 2 | 1999 | 2 | 0.090 |
Why?
|
| Cholesterol | 2 | 2005 | 21 | 0.090 |
Why?
|
| beta Catenin | 1 | 2008 | 16 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 33 | 0.090 |
Why?
|
| Androgens | 1 | 2008 | 29 | 0.080 |
Why?
|
| Follistatin | 1 | 2008 | 18 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2004 | 133 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2020 | 180 | 0.080 |
Why?
|
| Lipoproteins, HDL | 2 | 2005 | 3 | 0.080 |
Why?
|
| Apolipoproteins A | 1 | 1987 | 1 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 40 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2002 | 35 | 0.080 |
Why?
|
| Neurons | 2 | 1997 | 41 | 0.070 |
Why?
|
| Muscle, Smooth | 2 | 1997 | 36 | 0.070 |
Why?
|
| Swine | 2 | 2004 | 3 | 0.070 |
Why?
|
| Lipid Metabolism | 2 | 2004 | 24 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2004 | 116 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2005 | 2 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 4 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2005 | 4 | 0.070 |
Why?
|
| Echocardiography | 1 | 2005 | 9 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 24 | 0.070 |
Why?
|
| Anion Exchange Resins | 1 | 2005 | 1 | 0.070 |
Why?
|
| Methods | 1 | 2005 | 2 | 0.070 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 3 | 0.070 |
Why?
|
| Lipoproteins, VLDL | 1 | 2005 | 2 | 0.070 |
Why?
|
| Preservation, Biological | 1 | 2005 | 2 | 0.070 |
Why?
|
| Specimen Handling | 1 | 2005 | 4 | 0.070 |
Why?
|
| Cell Division | 2 | 2002 | 39 | 0.070 |
Why?
|
| Child | 1 | 2005 | 126 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2004 | 1 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 6 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2004 | 1 | 0.060 |
Why?
|
| Catheterization | 1 | 2004 | 4 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 6 | 0.060 |
Why?
|
| Bone Development | 1 | 2003 | 3 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 16 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1989 | 3 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 2 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2003 | 70 | 0.060 |
Why?
|
| Catalysis | 1 | 2002 | 4 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2002 | 2 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 3 | 0.060 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 1 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2002 | 2 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 22 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 2 | 1999 | 3 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2002 | 119 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 9 | 0.050 |
Why?
|
| Zinc Fingers | 2 | 1992 | 3 | 0.050 |
Why?
|
| Mutation | 2 | 1998 | 28 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 4 | 0.050 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 5 | 0.050 |
Why?
|
| Cadherins | 1 | 2020 | 6 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2020 | 15 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1990 | 3 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2020 | 18 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 32 | 0.050 |
Why?
|
| Machine Learning | 1 | 2020 | 7 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2020 | 55 | 0.050 |
Why?
|
| Biomarkers | 1 | 2020 | 58 | 0.050 |
Why?
|
| Apolipoprotein A-I | 2 | 1992 | 2 | 0.050 |
Why?
|
| Spermine | 1 | 2000 | 4 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2000 | 7 | 0.050 |
Why?
|
| DNA Probes | 2 | 1990 | 4 | 0.050 |
Why?
|
| Urinalysis | 1 | 2019 | 2 | 0.050 |
Why?
|
| Risk Factors | 1 | 2020 | 240 | 0.050 |
Why?
|
| Creatinine | 1 | 2019 | 10 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 1998 | 9 | 0.050 |
Why?
|
| Genes | 2 | 1992 | 2 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 26 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 46 | 0.050 |
Why?
|
| Saphenous Vein | 1 | 1999 | 1 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1999 | 1 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 3 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 55 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 267 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 17 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 19 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1999 | 2 | 0.040 |
Why?
|
| Collagenases | 1 | 1999 | 3 | 0.040 |
Why?
|
| Glycated Hemoglobin A | 1 | 2019 | 64 | 0.040 |
Why?
|
| United States | 1 | 2020 | 324 | 0.040 |
Why?
|
| Homozygote | 1 | 1998 | 1 | 0.040 |
Why?
|
| Heterozygote | 1 | 1998 | 2 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2004 | 15 | 0.040 |
Why?
|
| Gonadotropins | 1 | 1997 | 2 | 0.040 |
Why?
|
| Germ Cells | 1 | 1997 | 4 | 0.040 |
Why?
|
| Testis | 1 | 1997 | 16 | 0.040 |
Why?
|
| Glycation End Products, Advanced | 1 | 1997 | 2 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 1997 | 3 | 0.040 |
Why?
|
| Diet, Atherogenic | 1 | 1997 | 2 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 1997 | 3 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 38 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 1997 | 14 | 0.040 |
Why?
|
| Penile Erection | 1 | 1997 | 33 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 1996 | 1 | 0.040 |
Why?
|
| Sertoli Cells | 1 | 1996 | 5 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 1997 | 67 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 1996 | 9 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1987 | 3 | 0.040 |
Why?
|
| Urinary Tract | 1 | 1996 | 4 | 0.040 |
Why?
|
| Aging | 1 | 1997 | 101 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1995 | 4 | 0.030 |
Why?
|
| Cytokines | 1 | 1995 | 47 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 26 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 14 | 0.030 |
Why?
|
| Young Adult | 1 | 2014 | 175 | 0.030 |
Why?
|
| Toll-Like Receptors | 2 | 2004 | 15 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2004 | 16 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1992 | 1 | 0.030 |
Why?
|
| Schizosaccharomyces | 1 | 1992 | 1 | 0.030 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 1992 | 1 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 1992 | 3 | 0.030 |
Why?
|
| Chickens | 2 | 1992 | 2 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 1992 | 24 | 0.030 |
Why?
|
| Transfection | 3 | 1998 | 46 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 5 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cell Communication | 1 | 1991 | 5 | 0.030 |
Why?
|
| Selenomethionine | 1 | 2011 | 4 | 0.030 |
Why?
|
| Cell Line | 3 | 1998 | 80 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 14 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 15 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 30 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1991 | 21 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 24 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1990 | 1 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2011 | 24 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 81 | 0.020 |
Why?
|
| Ferrous Compounds | 1 | 1990 | 1 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1990 | 1 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1990 | 3 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 44 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1989 | 17 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 1989 | 1 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1989 | 1 | 0.020 |
Why?
|
| Binding Sites | 1 | 1989 | 14 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1989 | 6 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1989 | 7 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1989 | 32 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1989 | 45 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 4 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 7 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 6 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 11 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 16 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 18 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 32 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1998 | 5 | 0.020 |
Why?
|
| Wallerian Degeneration | 1 | 1987 | 1 | 0.020 |
Why?
|
| Muscles | 1 | 1987 | 17 | 0.020 |
Why?
|
| Testosterone | 2 | 1997 | 76 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1997 | 15 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 1997 | 3 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1985 | 3 | 0.020 |
Why?
|
| S-Nitrosoglutathione | 2 | 1995 | 2 | 0.020 |
Why?
|
| Nitroso Compounds | 2 | 1995 | 8 | 0.020 |
Why?
|
| Glutathione | 2 | 1995 | 13 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1997 | 6 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 1 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 1 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2004 | 6 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 10 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 11 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2004 | 10 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2004 | 8 | 0.020 |
Why?
|
| Lipids | 1 | 2004 | 20 | 0.020 |
Why?
|
| Phenotype | 1 | 2004 | 40 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 12 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2004 | 1 | 0.020 |
Why?
|
| E-Selectin | 1 | 2004 | 1 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2004 | 3 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2004 | 3 | 0.020 |
Why?
|
| Tunica Media | 1 | 2004 | 4 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 7 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 2 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 4 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 2004 | 2 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 6 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2004 | 14 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 35 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 114 | 0.010 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 92 | 0.010 |
Why?
|
| Bleeding Time | 1 | 2000 | 1 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 1 | 0.010 |
Why?
|
| Polyglycolic Acid | 1 | 2000 | 1 | 0.010 |
Why?
|
| Polymers | 1 | 2000 | 2 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2000 | 3 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 9 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2000 | 13 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2000 | 4 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 12 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1998 | 2 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 7 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1998 | 26 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1998 | 13 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 7 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1997 | 14 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 16 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1997 | 26 | 0.010 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 1997 | 1 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1997 | 1 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 42 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1997 | 4 | 0.010 |
Why?
|
| Codon | 1 | 1997 | 4 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 33 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 1997 | 18 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1996 | 1 | 0.010 |
Why?
|
| Colforsin | 1 | 1996 | 5 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 18 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1997 | 37 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1995 | 1 | 0.010 |
Why?
|
| Guanidines | 1 | 1995 | 1 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 2 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1995 | 4 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1995 | 3 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 9 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 3 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1995 | 27 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1995 | 2 | 0.010 |
Why?
|
| Molsidomine | 1 | 1995 | 4 | 0.010 |
Why?
|
| Conjugation, Genetic | 1 | 1992 | 1 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1992 | 1 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 1992 | 1 | 0.010 |
Why?
|
| Spores, Fungal | 1 | 1992 | 1 | 0.010 |
Why?
|
| Genes, Suppressor | 1 | 1992 | 1 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 3 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 2 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 2 | 0.010 |
Why?
|
| Genes, ras | 1 | 1992 | 6 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1992 | 37 | 0.010 |
Why?
|
| Quail | 1 | 1992 | 1 | 0.010 |
Why?
|
| Connexins | 1 | 1991 | 1 | 0.010 |
Why?
|
| Fibronectins | 1 | 1991 | 6 | 0.010 |
Why?
|
| Collagen | 1 | 1991 | 26 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1990 | 2 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 5 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 1989 | 4 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1989 | 4 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1989 | 1 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1989 | 3 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1985 | 1 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1985 | 1 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1985 | 1 | 0.000 |
Why?
|
| Trypsin | 1 | 1985 | 2 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 4 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1985 | 6 | 0.000 |
Why?
|
| Lymphokines | 1 | 1985 | 11 | 0.000 |
Why?
|
| Amino Acids | 1 | 1985 | 16 | 0.000 |
Why?
|
| Insulin | 1 | 1985 | 109 | 0.000 |
Why?
|